Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy
Author(s) -
Richard L. Tannen,
Mark G. Weiner,
Dawei Xie,
Kurt T. Barnhart
Publication year - 2007
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/dem031
Subject(s) - estrogen , estrogen replacement therapy , progestin , medicine , estrogen therapy , hormone replacement therapy (female to male) , menopause , gynecology , endocrinology , testosterone (patch)
In the Women's Health Initiative Randomized Controlled Trial (WHI RCT), estrogen-only treatment compared with combined estrogen-progestin treatment resulted in less coronary artery disease, no increase in breast cancer and no reduction in colorectal cancer. Since we previously reasonably replicated the combined estrogen-progestin WHI RCT using the UK General Practice Research Database (GPRD), estrogen-only treatment was investigated using a similar methodology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom